80 results
Page 4 of 4
8-K
rn5j 5i7986jn3qfwp
7 Feb 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
425
5r6h 2ftpmkniuvugio
7 Feb 20
Business combination disclosure
12:00am
S-4
g6zfz61n3se
4 Feb 20
Registration of securities issued in business combination transactions
6:26am
8-K
EX-2.1
5suhbfvox19ihdyo7
21 Jan 20
Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger Agreement
9:20am
425
EX-2.1
5ctpu9w
21 Jan 20
Business combination disclosure
9:19am
8-K
28fqkm2b
26 Nov 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:00am
8-K
EX-10.1
6187i l3p
6 Nov 19
Entry into a Material Definitive Agreement
9:56pm
8-K
EX-10.1
jfl9antk
24 Jul 19
Entry into a Material Definitive Agreement
5:29pm
8-K
EX-99.1
cb9bomifme kj
11 Jul 19
Other Events
5:22pm
8-K
8glgxx5c
1 Jul 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:48pm
8-K
EX-10.2
gavw8wjoihmv
2 Jul 18
Ritter Pharmaceuticals Announces Appointment of Andrew J. Ritter as Chief Executive Officer
6:01am
10-K
9tf0u8
21 Mar 16
Annual report
12:00am
DRS
nxmb7vonkx
29 Jan 15
Draft registration statement
12:00am